Investor Overview

Our Investor Information

Company Overview

Rhythm Pharmaceuticals is a commercial-stage biopharmaceutical company committed to transforming the care for patients living with rare genetic diseases of obesity.

Latest Presentations
View All

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Annual Report
Press Releases
April 1, 2024
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
See Details
March 25, 2024
Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist
See Details
Upcoming Events
More events are coming soon.
Investor FAQs
More FAQs are coming soon.

Founded

Delaware, November 2008

Headquarters

222 Berkeley Street, 12th Floor
Boston, MA 02116

CUSIP number

76243J105

Transfer Agent

Computershare Trust Company, Inc.
250 Royall Street
Canton, MA 02021
www.computershare.com
US Phone: +1-800-962-4284
International Phone: + 1-781-575-3120